Country: Jordan
Language: English
Source: JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)
Dried Ivy Leaf Extract 80 mg
شركة دار الدواء للتنمية والأستثمار - Dar Al Dawa Development and Investment Co Ltd
R05CA12
Dried Ivy Leaf Extract 80 mg
80 mg
10
Dar Al Dawa Development and Investment Co Ltd/Jordan (الاردن)
2.29 :سعر الجمهور + الضريبة
PANTONE BLACK U _Color_ SIZE: 135X205 MM ITEM CODE: 4232695600 PHARMA CODE: 966 READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. WHAT LIBLAB® COUGH SUPPOSITORY IS AND WHAT IT IS USED FOR 2. BEFORE YOU TAKE LIBLAB® COUGH SUPPOSITORIES 3. HOW TO TAKE LIBLAB® COUGH SUPPOSITORIES 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE LIBLAB® COUGH SUPPOSITORIES 6. FURTHER INFORMATION 1. WHAT LIBLAB® COUGH SUPPOSITORY IS AND WHAT IT IS USED FOR LIBLAB® is a herbal Cough medicine, containing dried ivy leaf extract as active ingredient. LIBLAB® liquefies mucus, relaxes convulsive cough and calms coughing. In this way, LIBLAB® combats the typical complaints of bronchitis: increased formation of viscous mucus, shortness of breath and irritation of the throat. Troublesome and painful coughing is calmed, but not blocked, which is important for being able to cough up the mucus and thereby allow for trouble-free deep breathing. LIBLAB® cough suppositories are indicated for acute catarrh of the respiratory tract accompanied by coughing; symptomatic treatment of chronic inflammatory bronchial diseases. 2. BEFORE YOU TAKE LIBLAB® COUGH SUPPOSITORIES DO NOT TAKE LIBLAB® COUGH SUPPOSITORIES If you are hypersensitive (allergic) to the active substances or any of the other ingredients of LIBLAB® . Children under 2 years of age because of the general risk of aggravation of respiratory symptoms through secretolytic drugs. TAKING OTHER MEDICINES, HERBAL OR DIETARY SUPPLEMENTS Adverse effects have not become known with the use of LIBLAB® cough suppositories and other medicines. This preparat Read the complete document